Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)

Name: Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)
License: Public Domain

Merck Sharp & Dohme LLC

ClinicalTrials.gov · Datasets · License: Public Domain

neoplasm malignant

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 448177
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.